KLK3 and prostate carcinoma: We also replicated the previously associated prostate-specific antigen (PSA) variant, rs17632542 [31] (KLK3, OR [95% CI] = 1.49 [1.28, 1.73], p = 3.87 × 10−7) in individuals with at least one prostate cancer diagnosis.